Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Journal of the Egyptian Womenʼs Dermatologic SocietyOpen Access

Ixekizumab in dermatology: revisited

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAditya Kumar BubnaVVVinayak Viplav

Discussion

Loading...

Member takes

Overview

Narrative review discusses ixekizumab's efficacy in psoriasis and other dermatologic disorders, suggesting broader applications.

Key Points

  • Ixekizumab is shown to effectively manage psoriasis and psoriatic arthritis, highlighting its versatility.
  • It has demonstrated a superior efficacy compared to other biologics, like etanercept and ustekinumab, in treating plaque psoriasis.
  • Beyond psoriasis, ixekizumab is effective for conditions like bullous pemphigoid and hidradenitis suppurativa.
  • Its safety profile is acceptable, indicating it can be used for various dermatologic disorders without significant risk.

Cite This Study

Bubna et al. (2025) studied this question.

synapsesocial.com/papers/68bb49db6d6d5674bcd00271https://doi.org/10.4103/jewd.jewd_46_24
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Updates on the Treatment of Erythrodermic Psoriasis2021 · 45 citations
  2. 2Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa2015 · 221 citations
  3. 3Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis2021 · 37 citations
  4. 4Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data2016 · 131 citations
  5. 5Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides2008 · 378 citations